A Special Diet to Help Manage Ulcerative Colitis
Tests a high protein, high fiber diet in adults with ulcerative colitis.
Key facts
- Who runs it
- University of Minnesota
- Where
- Minneapolis, United StatesSee the site
- Trial code
- Registry title
- Microbiome-targeted Diet Therapy in Ulcerative Colitis
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 4 Nov 2026
- Expected to end
- 1 Jun 2029
- Type of study
- Interventional
- Treatments tested
- High Protein, High Fiber (HPHF) Diet
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with mild ulcerative colitis to test a high-protein, high-fiber diet.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Ulcerative colitis diagnosed by symptoms and endoscopy, lasting at least 3 months, with an endoscopic severity score (UCEIS) of 4 or lower within 90 days before randomization. Moderate or severe disease (UCEIS 5 or higher) cannot join.
- Earlier treatment
- Stable dose of UC treatment, or no treatment apart from steroids: at least 4 weeks if no medication or 5-ASA, at least 8 weeks for immunomodulatory therapy, at least 12 weeks for biologics.
Main reasons for not taking part
- Stomach surgery or bowel resection in the past
- Antibiotic use within 3 months, or antibiotics expected during the study
- Pregnancy or breastfeeding
- Anaphylactic food allergies or intolerance of high dietary fiber
- Habitual vegan diet, or ongoing alcohol or drug abuse
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Ability and willingness to provide informed consent
- Age at least 18 years old
- Diagnosis of UC based on clinical and endoscopic criteria
- UC duration of at least 3 months
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score ≤4 within 90 days of randomization
- On a stable dose or no existing UC therapies (apart from steroids) for defined periods (as outlined below); ≥4 weeks if no medication, 5-ASA; ≥8 wk for immunomodulatory therapy; ≥12 wk for biologics
- Ability to comply with study requirements in the opinion of the primary investigator
Who cannot take part
- Ongoing alcohol or drug abuse
- History of stomach surgery or bowel resection
- History of anaphylactic food allergies
- Moderate or severe UC as defined by UCEIS ≥5
- Antibiotic use within 3 months
- Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)
- Pregnancy or breastfeeding
- Intolerance of high dietary fiber content
- Habitual vegan diet pattern
- Insufficient freezer space to accommodate meal delivery
Where in United States
- University of MinnesotaMinneapolis, United StatesContact: Levi TeigenTaking people
About the trial
What the trial wants to find out
The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.
The group in the trial
- On-Off Cycling InterventionTreatment being tested
1 week standard diet, followed by 1 week high-protein, high-fiber diet, followed by 1 week standard diet, followed by 1 week high-protein, high-fiber diet
Treatment: High Protein, High Fiber (HPHF) Diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Microbiome-targeted Diet Therapy in Ulcerative Colitis
- Plain-language title
- A Special Diet to Help Manage Ulcerative ColitisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 9 November 2026